European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies | Zendy

Martin Hoenigl | Zendy; Volker Strenger | Zendy; Walter Buzina | Zendy; Thomas Valentin | Zendy; Christoph Koidl | Zendy; Albert Wölfler | Zendy; Katharina Seeber | Zendy; Angelika Valentin | Zendy; Anna T. Strohmeier | Zendy; Ines ZollnerSchwetz | Zendy; Reinhard B. Raggam | Zendy; C. Urban | Zendy; Cornelia LassFlörl | Zendy; W. Linkesch | Zendy; Robert Krause | Zendy

Open Access

European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies

Author(s) -

Martin Hoenigl,

Volker Strenger,

Walter Buzina,

Thomas Valentin,

Christoph Koidl,

Albert Wölfler,

Katharina Seeber,

Angelika Valentin,

Anna T. Strohmeier,

Ines ZollnerSchwetz,

Reinhard B. Raggam,

C. Urban,

Cornelia LassFlörl,

W. Linkesch,

Robert Krause

Publication year - 2012

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dks155

Subject(s) - neutropenia , medicine , cancer , transplantation , immunology , gastroenterology , chemotherapy

Fulfilment of host factors defined by the revised European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) criteria is required for establishing the diagnosis of possible or probable invasive fungal infection (IFI). This case-control study evaluates EORTC/MSG host factors among patients with haematological malignancies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research